Objective: Sphingosine-1-phosphate (S-1-P), a potent lysophospholipid mediator which is released from platelets during clotting, activates a G-protein-gated inwardly rectifying K + current (GIRK) in atrial and sino-atrial node myocytes. We denote this current I K(S-1-P). A similar GIRK, which is activated by acetylcholine (ACh) and denoted I K(ACh) , is expressed in atrium. It shortens the action potential duration (APD) and reduces the effective refractory period (ERP). We have examined the effect of S-1-P on APD in guinea pig atrial myocytes by characterizing the rectification properties of I K(S-1-P) and evaluating whether I K(S-1-P) and I K(ACh) exhibit convergence/occlusion. Methods: Membrane potential and K + currents were recorded from guinea pig atrial myocytes. Inwardly rectifying K + currents were recorded using a ramp voltage clamp waveform between + 30 to À 130mV from a holding potential of À7 mV. Agonist-induced current changes were obtained by subtracting the control current. Results: S-1-P (1 and 10 nM) altered both passive and active properties of atrial myocytes. S-1-P increased the threshold current for excitation and decreased the time constant of the subthreshold electrotonic potentials. In addition, both APD 50 and APD 90 were decreased substantially. Voltage clamp analysis showed that the outward conductance of I K(IR) ( G K(IR)out ) was 134.8 T 11.3 pS pF À 1 (n = 19) in S-1-P (100 nM), and 207.0 T 19.6pS pF À 1 (n = 18) in ACh (10 AM). The ratio of G K(IR)out : G K(IR)in was about 0.7 for both S-1-P and ACh. The EC 50 values for the activation of G K(IR)out and G K(IR)in by S-1-P were 1.6 and 1.3 nM, respectively. Addition of S-1-P (100 nM) after the effect of ACh (10 AM) had developed fully caused very little additional change. Conclusion: I K(S-1-P) is carried by weakly inwardly-rectifying K + channels that are the same as those activated by ACh. This K + current can markedly shorten APD in guinea pig atrial myocytes. This effect would be expected to increase the incidence of atrial rhythm disturbances.
Introduction
Sphingosine-1-phosphate (S-1-P), is a membrane-derived lipid signaling substance. It can modulate cell proliferation, migration, and differentiation as well as promoting apoptosis and other pathophysiological phenomena in various tissues, including the heart and blood vessels [1, 2] . S-1-P binds to well-defined plasmalemma receptor proteins (S-1-P/Edg receptors) which are linked to specific G proteins [3, 4] .
In guinea pig atrial myocytes, S-1-P, at nanomolar concentrations, produces an inwardly rectifying K + current (I K(S-1-P) ) via a pertussis toxin-sensitive G protein [5] . I K(S-1-P) increases the cycle length in rabbit sino-atrial node cells [6] . Intravenous administration of S-1-P causes significant negative chronotropic and inotropic effects in rat heart [7] . 0008 Human trials have demonstrated that FTY720, an agent which can alter immune status and is used in kidney transplant procedures [8, 9] , produces transient bradycardia and lymphopenia [10] . A recent study in mice [11] has shown that this FTY720-induced decrease in heart rate is also caused by activation of G-protein-gated K + channels.
In atrial myocytes, a G protein coupled receptor (GPCR)mediated K + conductance has been shown to markedly accelerate repolarization and may also produce a small hyperpolarization [12, 13] . This shortening of APD in atrial myocytes decreases the effective refractory period (ERP) and increases its spatial heterogeneity. These effects contribute to the initiation and maintenance of supraventricular arrhythmias, including atrial flutter and fibrillation (AF) [14, 15] . Chronic AF is often accompanied by hypercoagulable state of the blood [16] . As S-1-P can be released from platelets by thrombin [17, 18] or from blood clots [19, 20] , it could shorten the APD and thus may predispose to supraventricular arrhythmias.
S-1-P-induced K + current and associated S-1-P receptors have been identified in guinea pig atrial myocytes in culture [5, 21] as well as in freshly isolated atrial myocytes from mouse and human [22] . However, the effect of S-1-P on APD has not been studied in detail, and important biophysical principles which regulate the extent of the inward rectification of the I K(S-1-P) have not been determined (Ref. [1] is a comprehensive review of S-1-P effects in the cardiovascular system). In the present study using guinea pig atrial myocytes, the effects of S-1-P on APD were measured, and the ion transfer or rectifier properties of I K(S-1-P) were derived. In addition, we determined whether S-1-P activates K + currents other than the acetylcholinesensitive current, I K(ACh) . Our results demonstrate that S-1-P can markedly shorten APD, and that the corresponding K + current, I K(S-1-P) , exhibits weak inward rectification, very similar to I K(ACh) . Our analysis also confirms that I K(S-1-P) and I K(ACh) are carried by the same population of K + channels.
Methods
The experimental work in this paper was conducted at Toho University in accordance with the guiding principles for the care and use of animals in the field of Physiological Sciences of Japan. These procedures were also in accordance with the US National Institutes of Health (NIH Publication NO. 85-23, revised 1996).
Isolation of guinea pig atrial myocytes
Guinea pigs (300¨450g) were heparinized (1200 U kg À 1 i.p.) and then anesthetized with sodium pentobarbitone (50 mg kg À 1 i.p.). After cervical dislocation, hearts were quickly removed and Langendorff-perfused at 37 -C as follows: normal Tyrode's solution for 2 min, Ca 2+ -free Tyrode's solution for 5 min, and Ca 2+ -free Tyrode's solution with collagenase (1mg/ml, Sigma Type 1, Sigma Chemical, St Louis, MO, U.S.A.) for 15min. After this digestion with collagenase, the heart was perfused for 5min with a modified Kraftbrü he (KB) solution containing (mM): 100 potassium glutamate, 10 potassium aspartate, 25 KCl, 10 KH 2 PO 4 , 2 MgSO 4 , 20 taurine, 5 creatine base, 0.5 EGTA, 5 HEPES, 20 glucose, and 1mg ml À 1 BSA (pH adjusted to 7.3 with KOH). The atria were then removed, placed in KB solution and cut into small pieces. These atrial tissue segments were mechanically separated into single myocytes by gentle trituration at room temperature using a fire-polished Pasteur pipette with an inner diameter of 3 mm. Populations of isolated myocytes in KB solution were kept in the refrigerator until they were introduced into the recording chamber, approximately 20min before the patch clamp experiments began.
Electrophysiological measurements
Normal Tyrode's solution contained (in mM): 135 NaCl, 5.4 KCl, 2 CaCl 2 , 1 MgCl 2 , 0.33 NaH 2 PO 4 , 5 HEPES, and 10 glucose. pH was adjusted to 7.4 with NaOH. Effects of S-1-P on membrane potential were examined by superfusing the myocytes with normal Tyrode's solution. The voltage clamp experiments were conducted in the presence of 0.2 mM Cd 2+ which reversibly blocked L-type Ca 2+ current channels. The whole-cell pipette solution contained (in mM): 30 KCl, 100 potassium aspartate, 1 MgCl 2 , 5 HEPES, 10 EGTA, 3 Na 2 ATP and 0.3 GTP. pH was adjusted to 7.3 with KOH. Sphingosine-1-phosphate (S-1-P, Avanti, Alabaster, AL, U.S.A.) stock solution (0.1 mM) was prepared by incubating S-1-P in 4 mg/ml fatty acid-free bovine serum albumin solution for 30min at 37 -C. Acetylcholine chloride was from Sigma Ltd. (St. Louis, MO, U.S.A.).
For electrophysiological recordings, an aliquot of atrial myocyte suspension was allowed to settle for several minutes in a shallow rectangular chamber (approximate volume of 0.2ml) that was mounted on the stage of inverted microscope (IX-70, Olympus, Tokyo, Japan). This chamber was continuously superfused with modified Tyrode's solution at a flow rate of 1¨2ml min À 1 . S-1-P and other pharmacological agents were applied using a three-way switch connected in series to the tube that superfused the chamber. Patch pipettes were made from borosilicate glass and their resistance was 4¨8MV when filled with the pipette solution. Whole-cell currents were recorded by patch clamp (whole-cell mode) using Axopatch 1-D patch-clamp amplifier (Axon Instruments, Foster City, CA, U.S.A.). The junction potential between pipette solution and the Tyrode's solution was corrected by 10 mV as outlined in our previous study [23] . Membrane potential and voltage clamp procedures were controlled by pClamp (v. 6, Axon Instruments). Membrane currents were filtered at 2 kHz, digitized at 10kHz and stored. Both membrane potential and currents were digitized at 4 kHz and recorded continuously using Powerlab Software (Chart v. 5, ADInstruments, Castle Hill, Australia). Off-line data analysis was done using Igor Pro 4 or 5 (Wavemetrics Inc., Lake Oswego, OR, U.S.A.). Membrane capacitance (C m ) was estimated by integrating the charging transients elicited by a 5mV hyperpolarizing voltage clamp step from À 70mV. In most voltage clamp experiments ramp waveforms (150 ms in duration) were applied between + 30 and À 130mV from a holding potential (HP) of À 60 mV at 0.1 Hz. The outward ( G K(IR)out ) and inward conductances ( G K(IR)in ) of the inwardly rectifying K + currents were quantified by calculating the chord conductances at membrane potentials near the reversal potential (E rev ), i.e. within voltage ranges T40 mV from E rev . APs were elicited in current clamp experiments by applying 2.5 ms rectangular current steps. These stimuli were applied in 100 pA increments at 0.2Hz. Action potential durations were measured in terms of APD 30 , APD 50 and APD 90 . Each of these parameters represents the time interval between the time of the peak of AP and the time to a 30%, 50% or 90% decrease of the AP amplitude, respectively. All experiments were conducted at room temperature (22 T 1-C).
Data analysis
S-1-P-induced K + currents were obtained by subtracting all background currents which were recorded prior to application of S-1-P. The fixed dV / dt of the ramp command waveforms used in voltage clamp experiments resulted in there being no measurable changes in the charging or discharging of the capacitance of the myocyte. Possible differences of parameters among multiple groups were evaluated statistically using one or two way ANOVA, followed by Bonferroni's multiple comparison test, except when otherwise described (Prism v. 4, GraphPad Software Inc., San Diego, CA, U.S.A.). Statistical data are presented as means T s.e. of the mean. P < 0.05 was the criterion used to establish a statistically significant difference.
Results

Effects of S-1-P on atrial action potential repolarization
Superfusion of S-1-P (1 and 10 nM) onto atrial myocytes freshly isolated from the hearts of adult guinea pigs resulted in a marked and dose-dependent shortening of APD ( Fig. 1 ). S-1-P, even at a very low concentration (1 nM), caused significant shortening of APD and this effect was completely reversible (Fig. 1A) . A subsequent increase of S-1-P concentration, from 1 to 10 nM, caused a more pronounced shortening of APD. These large changes were not completely reversible during a 3 min washout ( Fig. 1B ). S-1-P consistently shortened APD when its effects were measured in terms of reductions in APD 30 , APD 50 and APD 90 . The S-1-P effects on APD 50 and APD 90 were statistically significant ( Fig. 1C ). APD 90 , which corresponds to ERP, decreased from its control value, 98.0 T 11.4ms (n = 25) to 42.5 T 5.2ms (n = 11, P < 0.001 compared to control) in the presence of 1 nM S-1-P. APD 90 was further reduced to 15.6 T 1.0pA (n = 14, P < 0.001 compared to control) by 10 nM S-1-P. We noted also that S-1-P increased the stimulus current needed to elicit an AP ( Fig. 2A¨C) . At a stimulus duration of 2.5ms, the threshold current increased from the control level 445 T 25pA (n = 23) to 550 T 20pA (n = 10, P < 0.05) in the presence of 1 nM S-1-P. The threshold current increased further to 930 T 65pA (n = 13, P < 0.001) when 10 nM S-1-P was present in the superfusate. These changes were due mainly to activation of I K(S-1-P) , which decreased the amplitude and time to peak of the electrotonic potentials during the stimulus current pulses (Fig. 2A¨C ). In the subthreshold range, the electrotonic changes in membrane potential decayed faster in the presence of S-1-P than in control conditions. The time constant of the decay phase of these electrotonic changes in membrane potential were decreased from control 5.6 T 0.4ms (n = 25) to 3.3 T 0.5ms (n = 11, P < 0.001 compared with control) by 1 nM S-1-P. In 10 nM S-1-P this time constant decreased further to 1.5 T 0.1ms (n = 14, P < 0.001 compared with control and 1 nM S-1-P). In contrast to these significant changes, the resting membrane potential (RP) changed only slightly. The control RP was À 82.5 T 0.5 mV (n = 25) and it was À 83.4 T 0.5 (n = 11) and À 84.2 T 0.8 mV (n = 14), in the presence of 1 and 10 nM S-1-P, respectively.
Voltage-dependent properties of S-1-P-activated K + current
The effects of S-1-P at levels between 1 and 100nM on inwardly rectifying K + currents, I K(IR) , were recorded from voltage clamped atrial myocytes in the presence of 5.4 mM [K + ] o . S-1-P resulted in rapid increases in both the holding current at À 60 mV and the current changes elicited by a 150-ms ramp waveform from +30 to À 130mV. In each experiment, S-1-P (10 nM) produced a marked increase in the outward current at membrane potentials positive to the resting potential, as well as increasing the inward current at hyperpolarized potentials (Fig. 3A) . The S-1-P sensitive current (I K(S-1-P) ) was isolated by subtracting the control or background current. It showed weak inward rectification and had an apparent reversal potential (E rev ) near the expected K + equilibrium potential (E K , À 88.5 mV). In contrast, in all experiments the control I -V exhibited much stronger inward rectification. This pattern of results was expected since it is known that the endogenous inwardly rectifying background K + current, I K1 , is due to Kir2.1/2.2 transcripts. Fig. 3B compares the I -Vs of I K(S-1-P) in the presence of 100 nM with I K(ACh) in the presence of 10AM ACh. Note that the I -Vs for both I K(S-1-P) and I K(ACh) show only moderate inward rectification. Specifically, these I -V relationships were approximately linear in the inward direction but in the outward direction the slope conductance decreased beginning at membrane potential at about 20mV positive than E rev . The voltage dependence of I K(S-1-P) was very similar to that of I K(ACh) . E rev for I K(S-1-P) and for I K(ACh) were close to the E K (Table 1) .
To provide a quantitative basis for comparing these two K + currents chord conductances were calculated. The outward chord conductance ( G K(IR)out ) and its inward equivalent ( G K(IR)in ) of I K(S-1-P) and I K(ACh) were calculated in a range of membrane potentials (T 40mV from E rev , see Table 1 ). Note that both G K(IR)out and G K(IR)in of I K(S-1-P) are smaller than those for I K(ACh) . This difference was statistically significant. Our results showed that the G K(IR)out activated by S-1-P was only approximately 0.6 as large as that activated by ACh.
Additional analysis of the rectifier properties of these ligand-gated inwardly rectifying K + channels was done in terms of an inward rectification factor, ( F ir ). We define this as the ratio: G K(IR)out / G K(IR)in [24] . This parameter was estimated from the raw data of each experiment in this series. F ir averaged approximately 0.7 for both I K(S-1-P) and I K(ACh) ( Table 1 ). The much more pronounced inward rectification of the background I K1 current yielded an F ir value of 0.16 T 0.01 (n = 36). The close agreement of the E rev values and F ir ratio between I K(S-1-P) and I K(ACh) strongly suggests that S-1-P and ACh can activate an identical population of K + channels in the atrial myocardium.
Dose -response relationship of S-1-P-induced K + currents
Progressive increases in S-1-P concentration produced corresponding increases in both G K(IR)out and G K(IR)in (Fig.  4) . The resulting dose -response curves were well fitted by a Hill equation with EC 50 of 1.6 and 1.3nM for G K(IR)out and G K(IR)in , respectively. The inward rectification factor ( F ir ), was not affected by changes in S-1-P concentration; 0.58 T 0.08 (n = 20) at 1nM, 0.68 T 0.08 (n = 18) at 10 nM. See also Table 1 . Fig. 2 . Effect of S-1-P on threshold current and electrotonic membrane potentials in guinea pig atrial myocytes. Electrotonic potentials due to subthreshold stimulation and the initial part of first action potential elicited by suprathreshold stimulation are shown. These depolarizing stimuli (with a duration of 2.5ms) were applied in increments of 100pA, as shown in bottom traces. The largest membrane potential change in B was generated by a premature excitation. Note that the passive electrotonic potentials caused by the subthreshold current pulses decayed exponentially, and that the rate of their decay was accelerated by S-1-P.
Do S-1-P-and ACh-mediated increases in K + current exhibit occlusion?
To more fully understand the molecular pharmacology of S-1-P effects in mammalian heart, it is important to determine: i) whether S-1-P regulates a different population of K + channels than those modulated by ACh, or ii) whether S-1-P can regulate the same K + channels that are opened by ACh. In principle, this can be tested by sequential application of saturating concentrations of each of these compounds, followed by measurement of maximal effects in terms of outward K + currents or the corresponding conductances. Accordingly, S-1-P and ACh were applied at their maximally effective concentrations. Either S-1-P (100 nM) or ACh (10 AM) was applied for 20¨30 s. This maneuver was followed immediately by simultaneous application of both agonists for 30 s at their maximal concentrations. The time of agonist exposure was kept very short to minimize the effects of receptor desensitization [5] . This protocol also allowed these agonists to be applied in the reverse order to the same myocytes (after an appropriate washout period). In this way, records of I K(S-1-P) or I K(ACh) were compared with the K + current activated by both S-1-P and ACh (I K(S-1-P+ACh) ). Both S-1-P and ACh activated K + currents during ramp waveform voltage clamp (Fig. 5A,B ). This analysis revealed that addition of ACh after S-1-P produced a significant increase in K + current I K(IR) (Fig. 5C ), suggesting that ACh could activate or recruit additional K + channels. In contrast, when the combination of S-1-P and Table 1 Comparison of parameters of S-1-P-and ACh-activated K + currents A, Typical effect of S-1-P on membrane current. Currents were elicited by a ramp voltage clamp waveform between +30 and À130mV, starting from HP of À60 mV. Time calibration bar indicates that the duration of the ramp pulse was similar to APD in Fig. 1 . Control current and current changes in the presence of S-1-P (10nM) are shown. I K(S-1-P) was obtained as the difference between the control current and the current after washout of S-1-P. B, Comparison of I -V relations of I K(S-1-P) and I K(ACh) denoted as averaged current densities (mean T s.e.). Note that these current densities are significantly different at several membrane potentials; ***P < 0.001, **P < 0.01, *P < 0.05.
ACh was applied following an ACh challenge only a small increase in K + was recorded (Fig. 5D ). Additional, complementary analysis of these results in terms of chord conductances yielded a similar pattern of results. Specifically, G K(IR)out obtained from these I -Vs showed that ACh alone can produce almost the same increase in G K(IR)out as that produced by the combination of S-1-P and ACh (Fig.  5E ). These findings can be expressed based on a normali-zation of the parameters for I K(S-1-P) and I K(ACh) to those for the combination, I K(S-1-P+ACh) . This analysis showed that the S-1-P-induced G K(IR)out was 0.53 T 0.06 (n = 9) of total G K(IR)out . In contrast, this ratio for the effect of ACh applied immediately before the S-1-P and ACh combination was 0.94 T 0.02 (n = 9). Similar results were obtained when the data were examined at membrane potentials negative to the reversal potential, that is in terms of G K(IR)in . 
Discussion
Our results demonstrate that S-1-P at nanomolar concentrations causes a marked shortening of APD in the guinea pig atrial myocytes. This effect is due to a G-proteinmediated activation of a weakly inwardly rectifying K + current. A decrease in APD will shorten the effective refractory period (ERP). This may predispose the atria to reentry-induced arrhythmias [14] . Atrial myocytes from AF patients show marked shortening of APD [28] . This working hypothesis is based in part on the well-known propensity of the atria to fibrillate during vagal stimulation [26] as a result of activation of I K(ACh) . Further, atrial rhythm disturbances are abolished in a murine model in which the K + channels responsible for K (ACh) are knocked out [27] .
APD shortening and threshold increase by S-1-P
Repolarization of the atrial AP is due to a net outward current which results from the algebraic sum of a number of different inward and outward currents [29] . The expression level of the classical inward rectifier K + channel (I K1 ) is very low in atrial myocytes from adult mammalian hearts. However, in response to a number of drugs or naturally occurring ligands other inwardly rectifying K + currents are activated. These are capable of generating quite substantial outward currents at membrane potentials corresponding to overshoot, plateau and terminal repolarization of AP (Fig. 3) . Our results confirm that I K(S-1-P) can markedly accelerate the repolarization and decrease the APD 50 and APD 90 (Fig. 1) . We acknowledge, however, that the marked shortening of APD shown in Fig.  1 would be unlikely to be this pronounced in the intact atrial syncytium. Two primary reasons for this are that S-1-P is unlikely to be liberated in a uniform fashion, thus its effects would be blunted through electrotonic interactions. In addition, under physiological conditions the intrinsic heart rate will be much higher than the stimulus rate of these experiments and this will produce a shorter control APD.
In principle, a S-1-P effect on L-type Ca 2+ current could contribute to the observed change in action potential duration. Yasui and Palade [28] have reported that sphingolipid compounds, specifically sphingosine at 25AM can alter the kinetics and the IV curve of the Ca 2+ current in rat ventricular myocytes. In contrast, our previous work on this current in rabbit sinoatrial node myocytes failed to identify any significant effect [6] . Under the experimental conditions in which the IV curves in this paper were obtained, any significant contribution of an inhibition of L-type Ca 2+ current by S-1-P can be excluded since Cd 2+ was present in the superfusate. Nevertheless, the remaining and important issue of whether S-1-P (at physiological levels) can modulate the Ca 2+ current, i.e., under adrenergic tone should be fully evaluated.
Our results have identified an effect of S-1-P on atrial excitability and changes in the time-course of the electrotonic potential which precedes action potential firing (threshold). Nanomolar concentrations of S-1-P increased the stimulus current needed to elicit the AP, and also reduced the time constant of the decay of subthreshold electrotonic potentials. The increase of threshold current could be primarily due to the decrease of resting membrane resistance due to activation of I K(S-1-P) . The size of this increase in the threshold current is related to, but not identical with, the decrease of the time constant. Nonlinearities in the small background K + currents and the very short applied stimuli result in the subthreshold depolarizations being partly due to charge redistribution under control conditions and in the presence of S-1-P. Following action potential firing and conduction, this S-1-P-induced increase in the threshold current for AP initiation can be proarrhythmic since it results in a decrease of conduction velocity. This would be expected to contribute to a reduction of the wavelength of the propagating wave of excitation (ERP Â conduction velocity) [14] . A reduction in this parameter is considered to be a classical indication of increased likelihood for reentrant rhythm disturbances.
Characterization of weak inward rectification of I K(S-1-P)
The weak inward rectification of G-protein-activated I K(IR) (GIRK) currents is an essential functional characteristic. This allows the generation of a substantial net outward current which contributes to the bradycardia. It also causes the shortening of APD and an increase in the firing threshold in atrial myocytes. We have analysed the inward rectifying properties of I K(IR) activated by S-1-P and ACh by calculating the ratio of outward to inward chord conductance ( F ir ) in normal [K + ] o (Table 1) .
G-protein-activated inwardly rectifying K + channels (GIRK, Kir3.X) in mammalian heart are tetramers consisting of Kir3.1 and Kir3.4 subunits [30] . GIRK is activated by direct interaction of beta/gamma subunits of G protein with Kir3.1/Kir3.4 channels [25] . Our F ir values are similar to those for Kir3.1/Kir3.4 channels activated by G beta/gamma subunits in HEK293 cells in the presence of 20mM [K + ] o [24] . Hommers et al. [24] reported that the extent of this inward rectification of Kir3.X channels can be reduced by increases in agonist concentration in feline atrial myocytes. A similar effect was observed in heterologous co-expression experiments designed to study G-protein subunit interactions with Kir3.1/3.4 expressed HEK293 cells. However, some of our observations differ from this pattern. Specifically: (i) the normalized I -V relations of I K(ACh) and I K(S-1-P) were similar, in spite of differences in their amplitude (Fig. 3B) , (ii) the EC 50 of G K(IR) was only weakly dependent on the direction of the current flow (Fig.  4) , and (iii) F ir was independent on S-1-P concentration. In combination, our results suggest that the inward rectification of I K(S-1-P) is not solely modulated by G-protein beta/gamma subunit levels in guinea pig atrial myocytes. An alternative explanation for the observed weak inward rectification is that it may be due to weak binding of intracellular polyamines to Kir3.4 subunits. It is known that the inward rectification of K (IR) channels is produced by binding of Mg 2+ and/or polyamines to these channels [25, 31] . Polyamines bind to the alpha subunits of Kir3.1/Kir3.4 channels near the selectivity filter of this K + channel, and this can cause inward rectification [32] . Furthermore, overexpression of Kir3.4 subunits can reduce this inward rectification in rat [33] and murine atrial myocytes [34] .
Convergence of I K(S-1-P) and I K(ACh)
I K(S-1-P) activation is initiated by the binding of S-1-P to tissue and/or cell specific S-1-P/Edg receptors. The Edg-3 (S-1-P 3 ) receptor has been suggested to be involved in S-1-P-induced activation of K + current in human and murine atrial myocytes [22] . Consistent with this, S-1-P-induced bradycardia can be suppressed by genetically deleting S-1-P 3 receptor in mice [35] and S-1-P binds to the human S-1-P 3 receptors with high affinity, yielding an apparent IC 50 of 0.2 nM [36] . The EC 50 in guinea pig [5, 22] , murine and human atrial myocytes [22] has been reported to be approximately 1 nM. We obtained a similar EC 50 for I K(S-1-P) activation based on the dose-dependence of G K(IR)out and G K(IR)in (Fig. 4) . This is an interesting result given that the S-1-P receptor of guinea pig heart has a much higher sensitivity to sphingosylphosphorylcholine [21, 22] than S-1-P 3 receptor of human and mouse heart [22] .
Previous experimental results have provided evidence that ligands which are linked to Kir3.1/3.4 can exhibit a nonadditive effect, which resembles saturation. This phenomenon has also been termed Focclusion_. A prime example is the adenosine (Ado)-activated I K(IR) with the maximal m 2 -muscarinic acetylcholine receptor (M 2 R)-mediated I K(ACh) in guinea pig atrial myocytes [37] . These results have been interpreted in terms of Ado-A 1 -activation converging on M 2 R-related biochemical signaling pathway at G beta/gamma or downstream I K(IR) channels. Indeed, previous work on cultured guinea pig atrial myocytes [5] has shown that the ACh-induced increase in holding current is significantly reduced by prior application of S-1-P. Thus, we conclude that S-1-P receptor signaling mechanism converges with the ACh -M 2 R activation system by activating the same population of weakly inwardly rectifying K + channels. However, since in the same myocyte I K(S-1-P) is smaller than I K(ACh) (Fig. 3B ) and application of ACh following a maximal concentration of S-1-P consistently induced an additional K + current, other factors must also be involved. It is now known that GIRK can be activated by interaction of receptor-associated G proteins with Kir3.1/Kir3.4 channels, that is, via protein -protein interactions which do not require the disassociation of beta/ gamma subunits from the receptors [38] . It therefore seems possible that S-1-P receptors are expressed at a smaller density than M 2 R receptors. This could contribute to altered levels of interaction with the Kir3.1/Kir3.4 channels that are in the immediate proximity of M 2 muscarinic receptors in the sarcolemma of guinea pig atrial myocytes.
Possible role of S-1-P in atrial rhythm disturbances
S-1-P is produced from sphingosine by sphingosine kinase, and it is stored in platelets [17] . S-1-P can be rapidly released from platelets (in the absence of or during their aggregation) into the extracellular environment on stimulation with agonists such as thrombin [17, 18] . An increase of S-1-P concentration in plasma from 0.2nM to 0.5 AM has been estimated during clotting [19] . Chronic AF is accompanied by a hypercoagulable state including increases of the tissue factor, Factor III, an initiator of coagulation [16] , and fibrin D-dimer, a marker of thrombogenesis [39] . Based on our findings, it seems plausible that S-1-P released from platelets could shorten the APD of atrial myocytes, and thus tend to induce atrial fibrillation/ flutter. S-1-P 3 receptors which mediate I (KS-1-P) activation are expressed in human atrium [22] . However, at present, neither the effect of S-1-P on the APD in human atrium nor the change of plasma S-1-P concentration in the setting of AF has been established. The multifactorial and very complex milieu from which supraventricular rhythm disturbances arise makes it necessary to insure that possible species differences (guinea pig to human) of receptor subtypes or relative contributions of different ion channels are properly accounted for (c.f. 22, 40, 41) .
